Age (years ± SD) |
57 ± 15 |
Male gender, n (%) |
171 (68.4) |
Diabetes, n (%) |
26 (10.4) |
Chronic obstructive pulmonary disease, n (%) |
28 (11.2) |
Hypertension, n (%) |
160 (64) |
Creatinine >1.5 mg/dl, n (%) |
18 (7.2) |
New York Heart Association functional class, n (%) |
II |
150 (60) |
III |
88 (35.2) |
IV |
12 (4.8) |
Ascending aortic pathology, n (%) |
Atherosclerotic aneurysm |
50 (20) |
Degenerative |
172 (68.8) |
Marfan |
28 (11.2) |
Type of valve dysfunction, n (%) |
Type I |
79 (31.6) |
Type II |
138 (55.2) |
Type I + II |
33 (13.2) |
Degree of aortic insufficiency n (%) |
I |
16 (2.4) |
II |
65 (26) |
III |
71 (28.4) |
IV |
98 (39.2) |
Ejection fraction % (mean ± standard deviation) |
0.43 ± 0.11 |